Cargando…

Evaluation of the influenza and respiratory syncytial virus (RSV) targets in the AusDiagnostics SARS-CoV-2, Influenza and RSV 8-well assay: sample pooling increases testing throughput

During the COVID-19 pandemic, sample pooling has proven an effective strategy to overcome the limitations of reagent shortages and expand laboratory testing capacity. The inclusion of influenza and respiratory syncytial virus (RSV) in a multiplex tandem PCR platform with SARS-CoV-2 provides useful d...

Descripción completa

Detalles Bibliográficos
Autores principales: Phan, Thuy, Tran, Ngoc Yen Kim, Gottlieb, Thomas, Siarakas, Steven, McKew, Genevieve
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Royal College of Pathologists of Australasia. Published by Elsevier B.V. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9021007/
https://www.ncbi.nlm.nih.gov/pubmed/35461715
http://dx.doi.org/10.1016/j.pathol.2022.02.002
_version_ 1784689701227069440
author Phan, Thuy
Tran, Ngoc Yen Kim
Gottlieb, Thomas
Siarakas, Steven
McKew, Genevieve
author_facet Phan, Thuy
Tran, Ngoc Yen Kim
Gottlieb, Thomas
Siarakas, Steven
McKew, Genevieve
author_sort Phan, Thuy
collection PubMed
description During the COVID-19 pandemic, sample pooling has proven an effective strategy to overcome the limitations of reagent shortages and expand laboratory testing capacity. The inclusion of influenza and respiratory syncytial virus (RSV) in a multiplex tandem PCR platform with SARS-CoV-2 provides useful diagnostic and infection control information. This study aimed to evaluate the performance of the influenza and RSV targets in the AusDiagnostics SARS-CoV-2, Influenza and RSV 8-well assay, including the effect of pooling samples on target detection. RSV target detection in clinical samples was compared to the Cepheid Xpert Xpress Flu/RSV assay as a reference standard. Samples were then tested in pools of four and detection rates were compared. Owing to the unavailability of clinical samples for influenza, only the effect of sample pooling on simulated samples was evaluated for these targets. RSV was detected in neat clinical samples with a positive percent agreement (PPA) of 100% and negative percent agreement (NPA) of 99.5% compared to the reference standard, demonstrating 99.7% agreement. This study demonstrates that sample pooling by four increases the average Ct value by 2.24, 2.29, 2.20 and 1.91 cycles for the target's influenza A, influenza A typing, influenza B and RSV, respectively. The commercial AusDiagnostics SARS-CoV-2, Influenza and RSV 8-well assay was able to detect influenza and RSV at an intermediate concentration within the limit of detection of the assay. Further studies to explore the applicability of sample pooling at the lower limit of detection of the assay is needed. Nevertheless, sample pooling has shown to be a viable strategy to increase testing throughput and reduce reagent usage. In addition, the multiplexed platform targeting various respiratory viruses assists with public health and infection control responses, clinical care, and patient management.
format Online
Article
Text
id pubmed-9021007
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Royal College of Pathologists of Australasia. Published by Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-90210072022-04-21 Evaluation of the influenza and respiratory syncytial virus (RSV) targets in the AusDiagnostics SARS-CoV-2, Influenza and RSV 8-well assay: sample pooling increases testing throughput Phan, Thuy Tran, Ngoc Yen Kim Gottlieb, Thomas Siarakas, Steven McKew, Genevieve Pathology Virology During the COVID-19 pandemic, sample pooling has proven an effective strategy to overcome the limitations of reagent shortages and expand laboratory testing capacity. The inclusion of influenza and respiratory syncytial virus (RSV) in a multiplex tandem PCR platform with SARS-CoV-2 provides useful diagnostic and infection control information. This study aimed to evaluate the performance of the influenza and RSV targets in the AusDiagnostics SARS-CoV-2, Influenza and RSV 8-well assay, including the effect of pooling samples on target detection. RSV target detection in clinical samples was compared to the Cepheid Xpert Xpress Flu/RSV assay as a reference standard. Samples were then tested in pools of four and detection rates were compared. Owing to the unavailability of clinical samples for influenza, only the effect of sample pooling on simulated samples was evaluated for these targets. RSV was detected in neat clinical samples with a positive percent agreement (PPA) of 100% and negative percent agreement (NPA) of 99.5% compared to the reference standard, demonstrating 99.7% agreement. This study demonstrates that sample pooling by four increases the average Ct value by 2.24, 2.29, 2.20 and 1.91 cycles for the target's influenza A, influenza A typing, influenza B and RSV, respectively. The commercial AusDiagnostics SARS-CoV-2, Influenza and RSV 8-well assay was able to detect influenza and RSV at an intermediate concentration within the limit of detection of the assay. Further studies to explore the applicability of sample pooling at the lower limit of detection of the assay is needed. Nevertheless, sample pooling has shown to be a viable strategy to increase testing throughput and reduce reagent usage. In addition, the multiplexed platform targeting various respiratory viruses assists with public health and infection control responses, clinical care, and patient management. Royal College of Pathologists of Australasia. Published by Elsevier B.V. 2022-06 2022-04-21 /pmc/articles/PMC9021007/ /pubmed/35461715 http://dx.doi.org/10.1016/j.pathol.2022.02.002 Text en © 2022 Royal College of Pathologists of Australasia. Published by Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Virology
Phan, Thuy
Tran, Ngoc Yen Kim
Gottlieb, Thomas
Siarakas, Steven
McKew, Genevieve
Evaluation of the influenza and respiratory syncytial virus (RSV) targets in the AusDiagnostics SARS-CoV-2, Influenza and RSV 8-well assay: sample pooling increases testing throughput
title Evaluation of the influenza and respiratory syncytial virus (RSV) targets in the AusDiagnostics SARS-CoV-2, Influenza and RSV 8-well assay: sample pooling increases testing throughput
title_full Evaluation of the influenza and respiratory syncytial virus (RSV) targets in the AusDiagnostics SARS-CoV-2, Influenza and RSV 8-well assay: sample pooling increases testing throughput
title_fullStr Evaluation of the influenza and respiratory syncytial virus (RSV) targets in the AusDiagnostics SARS-CoV-2, Influenza and RSV 8-well assay: sample pooling increases testing throughput
title_full_unstemmed Evaluation of the influenza and respiratory syncytial virus (RSV) targets in the AusDiagnostics SARS-CoV-2, Influenza and RSV 8-well assay: sample pooling increases testing throughput
title_short Evaluation of the influenza and respiratory syncytial virus (RSV) targets in the AusDiagnostics SARS-CoV-2, Influenza and RSV 8-well assay: sample pooling increases testing throughput
title_sort evaluation of the influenza and respiratory syncytial virus (rsv) targets in the ausdiagnostics sars-cov-2, influenza and rsv 8-well assay: sample pooling increases testing throughput
topic Virology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9021007/
https://www.ncbi.nlm.nih.gov/pubmed/35461715
http://dx.doi.org/10.1016/j.pathol.2022.02.002
work_keys_str_mv AT phanthuy evaluationoftheinfluenzaandrespiratorysyncytialvirusrsvtargetsintheausdiagnosticssarscov2influenzaandrsv8wellassaysamplepoolingincreasestestingthroughput
AT tranngocyenkim evaluationoftheinfluenzaandrespiratorysyncytialvirusrsvtargetsintheausdiagnosticssarscov2influenzaandrsv8wellassaysamplepoolingincreasestestingthroughput
AT gottliebthomas evaluationoftheinfluenzaandrespiratorysyncytialvirusrsvtargetsintheausdiagnosticssarscov2influenzaandrsv8wellassaysamplepoolingincreasestestingthroughput
AT siarakassteven evaluationoftheinfluenzaandrespiratorysyncytialvirusrsvtargetsintheausdiagnosticssarscov2influenzaandrsv8wellassaysamplepoolingincreasestestingthroughput
AT mckewgenevieve evaluationoftheinfluenzaandrespiratorysyncytialvirusrsvtargetsintheausdiagnosticssarscov2influenzaandrsv8wellassaysamplepoolingincreasestestingthroughput